MoneyWorks4Me

Lyka Labs - Quaterly Results

23 May 2023 Evaluate
The sales slipped to Rs. 194.55 millions for the March 2023 quarter as against Rs. 276.83 millions during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -30.03 millions as compared to Net Loss of Rs. -152.35 millions of corresponding quarter ended March 2022Operating profit for the quarter ended March 2023 decreased to 33.46 millions as compared to 122.22 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 194.55 276.83 -29.72 805.93 1643.49 -50.96 805.93 1643.49 -50.96
Other Income 6.15 6.60 -6.82 34.52 27.20 26.91 34.52 27.20 26.91
PBIDT 33.46 122.22 -72.62 190.52 1002.19 -80.99 190.52 1002.19 -80.99
Interest 28.13 29.10 -3.33 115.70 199.21 -41.92 115.70 199.21 -41.92
PBDT 3.94 65.09 -93.95 3.08 756.30 -99.59 3.08 756.30 -99.59
Depreciation 33.22 91.31 -63.62 135.16 153.89 -12.17 135.16 153.89 -12.17
PBT -29.28 -26.22 11.67 -132.08 602.41 -121.93 -132.08 602.41 -121.93
TAX 0.75 126.13 -99.41 0.78 203.38 -99.62 0.78 203.38 -99.62
Deferred Tax 4.23 126.13 -96.65 -1.29 203.38 -100.63 -1.29 203.38 -100.63
PAT -30.03 -152.35 -80.29 -132.86 399.03 -133.30 -132.86 399.03 -133.30
Equity 306.90 286.90 6.97 306.90 286.90 6.97 306.90 286.90 6.97
PBIDTM(%) 17.20 44.15 -61.04 23.64 60.98 -61.23 23.64 60.98 -61.23
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..